VM Voyageur Pharmaceuticals Ltd.

0.0804USD0.1150 CAD · TSXV0.00%Mkt Cap: 18.30M USDP/E: —

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, …

Key Statistics

Company
Market Cap18.30M USD
Enterprise Value17.06M USD
Revenue (TTM)35.55K USD
Gross Profit0 USD
Net Income (TTM)-2.47M USD
Revenue/Share0.00 USD
Last Price0.0804 USD
Fiscal Year EndNov 2025
MR QuarterAug 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA92918C1014
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-9.37
EV/Revenue479.82
P/S514.65
P/B6.05
EPS (TTM)-0.0070 USD
EPS (Forward)—
52W Range
0.048936% of range0.1363
52W High0.1363 USD
52W Low0.0489 USD
Profitability
Gross Margin0.00%
Oper. Margin-5122.52%
EBITDA Margin0.00%
Profit Margin-30231.56%
ROE-282.05%
ROA-113.77%
ROIC-272.16%
ROCE-273.32%
Growth
Revenue Growth32.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.02M USD
CapEx (TTM)—
FCF Margin-5166.59%
FCF Yield-10.04%
Net Debt-1.24M USD
Net Debt/EBITDA0.68
Net Debt/FCF—
Balance Sheet
Debt/Equity0.03
Current Ratio3.04
Quick Ratio2.47
Book Value/Sh0.01 USD
Cash/Share0.0056 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateMar 7, 2017
Splits
Last Split1:2
Split DateMar 7, 2017
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.227.58M
Float210.15M
Insiders7.34%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short682
Short (prev mo.)4.57K
Technical
SMA 500.0950 (-15.4%)
SMA 2000.0913 (-12.0%)
Beta0.37
S&P 52W Chg12.00%
Avg Vol (30d)120.69K
Avg Vol (10d)62.11K
Technical Indicators
RSI (14)41.0
MACD-0.0040
MACD Signal-0.0037
MACD Hist.-0.0004
BB Upper0.0959 USD
BB Middle0.0862 USD
BB Lower0.0765 USD
BB Width22.51%
ATR (14)0.0052 USD
Vol Ratio (20d)1.22x

About Voyageur Pharmaceuticals (CVE: VM)

›

Voyageur Pharmaceuticals (CVE: VM) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector.

The shares were at 0.1150 CAD on 19 November 2026, down 23.3% over 52 weeks. Its 52-week range is 0.0700 CAD to 0.1950 CAD: the price is 41.0% below the high and 64.3% above the low.

Its market capitalisation is 26.17M CAD.

Voyageur Pharmaceuticals reports return on equity of -282.1% and revenue up 32.7% year over year.

It holds more cash than debt, a net cash position of 1.77M CAD. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. The next earnings report is expected on 5 April 2027.